{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:52:43Z","timestamp":1793987563501,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.molmet.2024.102030","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T22:11:29Z","timestamp":1726611089000},"page":"102030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Improvement of MASLD and MASH by suppression of hepatic N-acetyltransferase 10"],"prefix":"10.1016","volume":"89","author":[{"given":"Yanying","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chao","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjian","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2024.102030_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41575-023-00846-4","article-title":"Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease","volume":"21","author":"Feng","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.molmet.2024.102030_bib2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s42255-024-00985-1","article-title":"From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research","volume":"6","author":"Hsu","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2024.102030_bib3","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2024.102030_bib4","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.32758","article-title":"Global burden of liver cancer in males and females: changing etiological basis and the growing contribution of NASH","volume":"77","author":"Tan","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2024.102030_bib5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41574-022-00711-5","article-title":"Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation","volume":"18","author":"Lonardo","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.molmet.2024.102030_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.molmet.2024.102030_bib7","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1038\/s41467-023-40943-1","article-title":"Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humans","volume":"14","author":"Hendrix","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2024.102030_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163018","article-title":"Hepatocyte SREBP signaling mediates clock communication within the liver","volume":"133","author":"Guan","year":"2023","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.molmet.2024.102030_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf8271","article-title":"Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1","volume":"376","author":"Gosis","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.molmet.2024.102030_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s42255-023-00786-y","article-title":"Physiological and pathological roles of lipogenesis","volume":"5","author":"Jeon","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2024.102030_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tem.2011.10.004","article-title":"SREBPs: metabolic integrators in physiology and metabolism","volume":"23","author":"Jeon","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.molmet.2024.102030_bib12","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.2337\/db18-0184","article-title":"SRY-box containing gene 4 promotes liver steatosis by upregulation of SREBP-1c","volume":"67","author":"Jiao","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2024.102030_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/gutjnl-2012-303150","article-title":"Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice","volume":"63","author":"Lu","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.molmet.2024.102030_bib14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jhep.2021.01.042","article-title":"FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease","volume":"75","author":"Liu","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.molmet.2024.102030_bib15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.apsb.2020.02.005","article-title":"NF- \u03ba B\/HDAC1\/SREBP1c pathway mediates the inflammation signal in progression of hepatic steatosis","volume":"10","author":"Guo","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.molmet.2024.102030_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hep.31220","article-title":"N(6)-methyladenosine reader protein YT521-B homology domain-containing 2 suppresses liver steatosis by regulation of mRNA stability of lipogenic genes","volume":"73","author":"Zhou","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2024.102030_bib17","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","article-title":"Acetylation of cytidine in mRNA promotes translation efficiency","volume":"175","author":"Arango","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.molmet.2024.102030_bib18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/CIRCRESAHA.122.322244","article-title":"NAT10 is involved in cardiac remodeling through ac4C-mediated transcriptomic regulation","volume":"133","author":"Shi","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.molmet.2024.102030_bib19","article-title":"PIWI-interacting RNA HAAPIR regulates cardiomyocyte death after myocardial infarction by promoting NAT10-mediated ac(4) C acetylation of Tfec mRNA","volume":"9","author":"Wang","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.molmet.2024.102030_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41392-021-00489-4","article-title":"NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.molmet.2024.102030_bib21","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.7150\/ijbs.65044","article-title":"Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies","volume":"18","author":"Fang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.molmet.2024.102030_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/nu9101072","article-title":"Animal models of nonalcoholic fatty liver disease \u2013 a starter's guide","volume":"9","author":"Van Herck","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.molmet.2024.102030_bib23","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2024.102030_bib24","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","article-title":"A\u00a0researcher's guide to preclinical mouse NASH models","volume":"4","author":"Gallage","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2024.102030_bib25","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s42255-022-00627-4","article-title":"Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis","volume":"4","author":"Zhou","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2024.102030_bib26","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/lifemeta\/loac034","article-title":"A\u00a0multi-omic landscape of steatosis-to-NASH progression","volume":"1","author":"Xiang","year":"2022","journal-title":"Life Metab"},{"key":"10.1016\/j.molmet.2024.102030_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev-virology-031413-085355","article-title":"AAV-mediated gene therapy for research and therapeutic purposes","volume":"1","author":"Samulski","year":"2014","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.molmet.2024.102030_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103145","article-title":"The positive feedback loop of the NAT10\/Mybbp1a\/p53 axis promotes cardiomyocyte ferroptosis to exacerbate cardiac I\/R injury","volume":"72","author":"Qu","year":"2024","journal-title":"Redox Biol"},{"key":"10.1016\/j.molmet.2024.102030_bib29","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41388-024-02975-9","article-title":"Dissecting the oncogenic properties of essential RNA-modifying enzymes: a focus on NAT10","volume":"43","author":"Dalhat","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.molmet.2024.102030_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108576","article-title":"Emerging roles of RNA ac4C modification and NAT10 in mammalian development and human diseases","volume":"253","author":"Zhang","year":"2024","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.molmet.2024.102030_bib31","doi-asserted-by":"crossref","first-page":"8514","DOI":"10.1093\/nar\/gkad628","article-title":"NAT10-mediated N4-acetylcytidine mRNA modification regulates self-renewal in human embryonic stem cells","volume":"51","author":"Liu","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.molmet.2024.102030_bib32","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41418-021-00899-5","article-title":"NAT10 regulates mitotic cell fate by acetylating Eg5 to control bipolar spindle assembly and chromosome segregation","volume":"29","author":"Zheng","year":"2022","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.molmet.2024.102030_bib33","article-title":"NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression","volume":"12","author":"Wang","year":"2022","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.molmet.2024.102030_bib34","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1038\/s41467-023-42135-3","article-title":"NAT10-dependent N(4)-acetylcytidine modification mediates PAN RNA stability, KSHV reactivation, and IFI16-related inflammasome activation","volume":"14","author":"Yan","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2024.102030_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13046-022-02586-w","article-title":"Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression","volume":"42","author":"Deng","year":"2023","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.molmet.2024.102030_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2023.121149","article-title":"NAT10 accelerates pulmonary fibrosis through N4-acetylated TGFB1-initiated epithelial-to-mesenchymal transition upon ambient fine particulate matter exposure","volume":"322","author":"Shenshen","year":"2023","journal-title":"Environ Pollut"},{"key":"10.1016\/j.molmet.2024.102030_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302705","article-title":"NAT10\/ac4C\/FOXP1 promotes malignant progression and facilitates immunosuppression by reprogramming glycolytic metabolism in cervical cancer","volume":"10","author":"Chen","year":"2023","journal-title":"Adv Sci"},{"key":"10.1016\/j.molmet.2024.102030_bib38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41422-023-00793-4","article-title":"Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner","volume":"33","author":"Liao","year":"2023","journal-title":"Cell Res"},{"key":"10.1016\/j.molmet.2024.102030_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12964-023-01321-y","article-title":"NAT10 mediated ac4C acetylation driven m(6)A modification via involvement of YTHDC1-LDHA\/PFKM regulates glycolysis and promotes osteosarcoma","volume":"22","author":"Mei","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.molmet.2024.102030_bib40","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/s42003-022-03868-x","article-title":"NAT10 regulates neutrophil pyroptosis in sepsis via acetylating ULK1 RNA and activating STING pathway","volume":"5","author":"Zhang","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.molmet.2024.102030_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.751802","article-title":"Role of neutrophils in the pathogenesis of nonalcoholic steatohepatitis","volume":"12","author":"Hwang","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.molmet.2024.102030_bib42","first-page":"131","article-title":"Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis","author":"He","year":"2021","journal-title":"J\u00a0Clin Investig"},{"issue":"6","key":"10.1016\/j.molmet.2024.102030_bib43","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s42255-024-01043-6","article-title":"An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"6","author":"Vacca","year":"2024","journal-title":"Nat Metab"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877824001613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877824001613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T07:41:25Z","timestamp":1732779685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877824001613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":43,"alternative-id":["S2212877824001613"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2024.102030","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement of MASLD and MASH by suppression of hepatic N-acetyltransferase 10","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2024.102030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"102030"}}